Log in or Sign up for Free to view tailored content for your specialty!
COPD News
Race-neutral equations for COPD trial eligibility may lead to more Black patients enrolled
SAN DIEGO — Using race-neutral equations to determine eligibility for COPD clinical trials may lead to higher percentages of Black patients enrolled, according to a poster presented at the American Thoracic Society International Conference.
Dupilumab lowers exacerbations, betters lung function in COPD with type 2 inflammation
SAN DIEGO — With dupilumab vs. placebo, adults with moderate to severe COPD and type 2 inflammation experienced fewer exacerbations, according to research presented at the American Thoracic Society International Conference.
Log in or Sign up for Free to view tailored content for your specialty!
Biologics lower exacerbations, hospitalizations in COPD, Th2 inflammation
SAN DIEGO — After 1 year of biologic therapy, patients with COPD and Th2 inflammation experienced fewer exacerbations and hospitalizations, according to research presented at the American Thoracic Society International Conference.
24-week ensifentrine improves dyspnea in moderate to severe COPD
SAN DIEGO — Among patients with moderate to severe COPD, 24-week ensifentrine improved dyspnea, according to research presented at the American Thoracic Society International Conference.
Tezepelumab decreases exacerbation rate, improves lung function, quality of life in COPD
SAN DIEGO — Among patients with moderate to very severe COPD receiving tezepelumab vs. placebo, the annualized rate of exacerbations dropped by 17%, according to research presented at the American Thoracic Society International Conference.
Beta-blocker bisoprolol fails to lower COPD exacerbations in patients at high risk
SAN DIEGO — Bisoprolol treatment yielded a similar yearly rate of COPD exacerbations that require oral corticosteroids and/or antibiotics to placebo, according to research presented at the American Thoracic Society International Conference.
Targeted lung denervation lowers COPD exacerbations, improves quality of life over 2 years
SAN DIEGO — Patients with COPD treated with targeted lung denervation along with optimal COPD therapy experienced fewer exacerbations over 2 years, according to research presented at the American Thoracic Society International Conference.
Less health care use with lung specialist-directed treatment in undiagnosed COPD, asthma
SAN DIEGO — Receiving treatment from a lung specialist for undiagnosed COPD or asthma lowered annual respiratory illness-related health care usage, according to research presented at the American Thoracic Society International Conference.
Triple combination COPD therapy lowers risk for cardiopulmonary outcomes
SAN DIEGO — Patients with COPD on budesonide/glycopyrrolate/formoterol fumarate had a lower risk for cardiopulmonary outcomes, according to research presented at the American Thoracic Society International Conference.
Lifestyle intervention helps with weight loss in COPD
A 12-month self-guided, low-intensity, video-based lifestyle intervention helped patients with COPD and obesity lose weight, according to results published in Annals of the American Thoracic Society.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read